![]() |
Volumn 63, Issue 5, 2011, Pages 749-762
|
Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERLEUKIN 1;
INTERLEUKIN 6;
MESSENGER RNA;
RESVERATROL;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ANTIOXIDANT ACTIVITY;
ARTICLE;
BODY COMPOSITION;
CACHEXIA;
CANCER CACHEXIA;
CANCER CELL;
CANCER INHIBITION;
CANCER TRANSPLANTATION;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG DISCRIMINATION;
DRUG EXCRETION;
DRUG METABOLISM;
ECHOCARDIOGRAPHY;
ENZYME INHIBITION;
FEMALE;
GASTROCNEMIUS MUSCLE;
HEART FAILURE;
HEART MUSCLE;
IN VIVO STUDY;
MOLECULAR INTERACTION;
MOUSE;
MUSCLE ATROPHY;
MUSCULAR DYSTROPHY;
NONHUMAN;
PROTEIN DEGRADATION;
REAL TIME POLYMERASE CHAIN REACTION;
RNA ISOLATION;
SARCOMERE;
SKELETAL MUSCLE;
ADENOCARCINOMA;
ADMINISTRATION, ORAL;
ANIMALS;
BODY COMPOSITION;
CACHEXIA;
CELL LINE, TUMOR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ECHOCARDIOGRAPHY;
FEMALE;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
HEART;
MICE;
MUSCLE PROTEINS;
MUSCLE, SKELETAL;
MUSCULAR ATROPHY;
MYOCARDIUM;
NEOPLASM TRANSPLANTATION;
RANDOM ALLOCATION;
RNA, MESSENGER;
STILBENES;
TRANSCRIPTION FACTOR RELA;
UBIQUITIN-PROTEIN LIGASES;
WEIGHT LOSS;
VITACEAE;
|
EID: 79960591506
PISSN: 01635581
EISSN: 15327914
Source Type: Journal
DOI: 10.1080/01635581.2011.563032 Document Type: Article |
Times cited : (83)
|
References (3)
|